Henry Schein Animal Health Completes Acquisition Of Majority Interest In Equine Products Company SmartPak

   Henry Schein Animal Health Completes Acquisition Of Majority Interest In
                       Equine Products Company SmartPak

PR Newswire

MELVILLE, N.Y., July 1, 2014

MELVILLE, N.Y., July 1, 2014 /PRNewswire/ --Henry Schein, Inc. (NASDAQ:
HSIC), the world's largest provider of health care products and services to
office-based dental, animal health and medical practitioners, announced today
that its U.S. Animal Health business, Henry Schein Animal Health, has
completed its acquisition of an approximate 60% ownership position in
SmartPak, the leading provider of equine supplements and horse supplies across
the United States. This transaction was first announced on May 22, 2014.

As previously reported, SmartPak had sales in 2013 of approximately $105
million. Private equity firm Oak Hill Capital Partners and SmartPak's
existing management team will own SmartPak's remaining equity. Financial
terms of the transaction were not disclosed. As stated when Henry Schein
first announced its agreement with SmartPak, Henry Schein expects the
transaction to be neutral to its earnings per share for the second half of
2014 and full-year 2015 and accretive to earnings per share in 2016 by
$0.02-$0.03.

"SmartPak is a highly regarded, fast-growing company that nicely complements
our existing U.S. animal health business, and we are delighted to have
completed this transaction," said Stanley M. Bergman, Chairman of the Board
and Chief Executive Officer of Henry Schein. "Henry Schein has built a
position of global leadership in the animal health market, and we look forward
to continued opportunities for growth with SmartPak and across our animal
health platform."

In addition to its U.S. Animal Health business, Henry Schein is the leading
distributor of products and services to veterinary practitioners in Australia
and New Zealand, and the leading pan-European veterinary distributor. Henry
Schein has European animal health operations in Austria, Belgium, the Czech
Republic, France, Germany, Ireland, Poland, Portugal, Spain, Switzerland, The
Netherlands, and the United Kingdom. In 2013, Henry Schein's Global Animal
Health business had sales of approximately $2.6 billion.

About SmartPak
From the feed room to the tack room, SmartPak offers innovative solutions to
help riders take great care of their horses. SmartPak was founded in 1999 with
the introduction of the patented SmartPak supplement feeding system.

The revolutionary, daily dose SmartPaks are custom-made for horses,
individually labeled and sealed for freshness. With the success of this
simple and convenient feeding system, SmartPak has continued to expand its
offering of quality products, including its own line of more than 55
supplement formulas called SmartSupplements, and a wide variety of tack,
equipment, and supplies. The Company has grown rapidly each year and is the
largest retailer of equestrian products in the United States. SmartPak's
success has been powered by a passion for delivering an unbeatable customer
experience, and the Company has been recognized with a Bizrate Circle of
Excellence award as well as an "Elite" rating from STELLAService. These
awards recognize retailers for providing excellent customer service to their
online customers. A nine-time Inc. 500/5000 list honoree, SmartPak is the only
equine company ever named to the Inc. 500 list.

About Oak Hill Capital Partners
Oak Hill Capital Partners is a private equity firm with more than $8 billion
of initial capital commitments from leading entrepreneurs, endowments,
foundations, corporations, pension funds, and global financial institutions.
Since inception 28 years ago, the professionals at Oak Hill Capital and its
predecessors have invested in more than 70 significant private equity
transactions across broad segments of the U.S. and global economies. Oak Hill
Capital applies an industry-focused, theme-based approach to investing in the
following sectors: Consumer, Retail & Distribution; Industrials; Media &
Communications; and Services. Oak Hill Capital works actively in partnership
with management to implement strategic and operational initiatives to create
franchise value.

About Henry Schein Animal Health, U.S.
Henry Schein Animal Health, based inDublin, Ohio, is a leading companion
animal health distribution company inthe United States. The Company employs
approximately 900 team members, including 300 field sales representatives and
200 telesales and customer support representatives. With 13 strategically
located, state-of-the-art distribution facilities and 10 inside sales centers,
the Company maintains a greater than a 99 percent order-fill ratio,
accomplishing its mission of providing the right product at the right place
and the right time.

Henry Schein Animal Health partners with over 480 channel suppliers to bring
veterinarians the broadest selection of products to companion animal, equine
and large animal practices including: dental, diagnostics, diets, equipment
and supplies, nutraceuticals, orthopedics, parasiticides, pharmaceuticals and
more.

In addition, the Company helps veterinarians grow their practice with its
strategic business solutions including AVImark® and ImproMed® Practice
Management Software, Henry Schein® Financial Services, Henry Schein®
ProRepair®, HRVetResource, Intelligent Inventory, Leadership Intelligence,
MyVetDirect.com® Home Delivery, Opperman Manual, OSHA Compliance Solutions,
Pet I.D. Cards, Privacy Edge Identify Theft Protection, Professional
Development Program, SmartPak™, VetPressOnline Client Communications,
Veterinary Instrumentation®, website development and more. For more
information, visitwww.henryscheinvet.com.

About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and
services to office-based dental, animal health and medical practitioners. The
Company also serves dental laboratories, government and institutional health
care clinics, and other alternate care sites. A Fortune 500® Company and a
member of the NASDAQ 100® Index, Henry Schein employs more than 17,000 Team
Schein Members and serves more than 800,000 customers.

The Company offers a comprehensive selection of products and services,
including value-added solutions for operating efficient practices and
delivering high-quality care. Henry Schein operates through a centralized and
automated distribution network, with a selection of more than 96,000 branded
products and Henry Schein private-brand products in stock, as well as more
than 110,000 additional products available as special-order items. The Company
also offers its customers exclusive, innovative technology solutions,
including practice management software and e-commerce solutions, as well as a
broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in
27 countries. The Company's sales reached a record $9.6 billion in 2013, and
have grown at a compound annual rate of approximately 16 percent since Henry
Schein became a public company in 1995. For more information, visit the Henry
Schein website at www.henryschein.com.

Cautionary Note Regarding Forward-Looking Statements

In accordance with the "Safe Harbor" provisions of the Private Securities
Litigation Reform Act of 1995, we provide the following cautionary remarks
regarding important factors that, among others, could cause future results to
differ materially from the forward-looking statements, expectations and
assumptions expressed or implied herein. All forward-looking statements made
by us are subject to risks and uncertainties and are not guarantees of future
performance. These forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause our actual results,
performance and achievements or industry results to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements. These statements are identified by the use
of such terms as "may," "could," "expect," "intend," "believe," "plan,"
"estimate," "forecast," "project," "anticipate" or other comparable terms. A
full discussion of our operations and financial condition, including factors
that may affect our business and future prospects, is contained in documents
we have filed with the SEC and will be contained in all subsequent periodic
filings we make with the SEC. These documents identify in detail important
risk factors that could cause our actual performance to differ materially from
current expectations.

Risk factors and uncertainties that could cause actual results to differ
materially from current and historical results include, but are not limited
to: effects of a highly competitive market; our dependence on third parties
for the manufacture and supply of our products; our dependence upon sales
personnel, customers, suppliers and manufacturers; our dependence on our
senior management; fluctuations in quarterly earnings; risks from expansion of
customer purchasing power and multi-tiered costing structures; possible
increases in the cost of shipping our products or other service issues with
our third-party shippers; general global macro-economic conditions;
disruptions in financial markets; possible volatility of the market price of
our common stock; changes in the health care industry; implementation of
health care laws; failure to comply with regulatory requirements and data
privacy laws; risks associated with our global operations; transitional
challenges associated with acquisitions and joint ventures, including the
failure to achieve anticipated synergies; financial risks associated with
acquisitions and joint ventures; litigation risks; the dependence on our
continued product development, technical support and successful marketing in
the technology segment; risks from challenges associated with the emergence of
potential increased competition by third party online commerce sites; risks
from disruption to our information systems; certain provisions in our
governing documents that may discourage third-party acquisitions of us; and
changes in tax legislation. The order in which these factors appear should not
be construed to indicate their relative importance or priority. We caution
that these factors may not be exhaustive and that many of these factors are
beyond our ability to control or predict. Accordingly, any forward-looking
statements contained herein should not be relied upon as a prediction of
actual results. We undertake no duty and have no obligation to update
forward-looking statements.

SOURCE Henry Schein, Inc.

Website: http://www.henryschein.com
Contact: Investors: Steven Paladino, Executive Vice President and Chief
Financial Officer, steven.paladino@henryschein.com, (631) 843-5500, or
Carolynne Borders, Vice President, Investor Relations,
carolynne.borders@henryschein.com, (631) 390-8105; Media, Susan Vassallo, Vice
President, Corporate Communications, susan.vassallo@henryschein.com, (631)
843-5562
 
Press spacebar to pause and continue. Press esc to stop.